Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice.
Accelerated atherosclerosis in dialysis patients is characterized by severe vascular calcification, and the magnitude of vascular calcification is associated with increased cardiovascular mortality. Calcification-dependent arterial stiffness is considered to be a major determinant of cardiac failure in uremia. Fetuin-A/alpha(2)-Heremans-Schmid glycoprotein is an abundant serum protein with powerful calcification inhibitory properties. Fetuin-A deficiency was recently linked to cardiovascular mortality in dialysis patients. Fetuin-A knockout (fetuin-KO) mice spontaneously develop widespread soft tissue calcification, including significant myocardial calcification, whereas larger arteries are spared. Therefore, this investigation offers the unique opportunity to study the functional role of isolated myocardial calcification independent of arterial stiffness by assessing the hemodynamics of fetuin-KO mice. Cardiac output in fetuin-KO mice was lower than in wild-type mice (fetuin-KO 1.81 +/- 0.18 versus WT 2.45 +/- 0.29 ml/min per g; P < 0.005), and fetuin-KO mice were refractory to dobutamine stimulation. Left ventricular relaxation was significantly impaired in fetuin-KO hearts with the relaxation index reduced by 23% (P < 0.005). After ischemia, fetuin-KO hearts displayed a continuous decline in left ventricular developed pressure after the initial phase of reperfusion, resulting in 77 +/- 15% of preischemic left ventricular developed pressure (P < 0.05 versus wild-type). In fetuin-KO mice, dystrophic cardiac calcification, with myocardial calcium contents increased 60-fold, was associated with profound induction of profibrotic TGF-beta and downstream collagen and fibronectin mRNA synthesis. In conclusion, independent of arterial stiffness, calcification-associated "myocardial stiffness" characterized by cardiac fibrosis, diastolic dysfunction, impaired tolerance to ischemia, and catecholamine resistance thus may constitute an underestimated cardiovascular risk factor that contributes to cardiac failure in calcification-prone states.
Merx
Marc W
MW
Medical Clinic I, RWTH University Hospital, Aachen, Germany. mmerx@ukaachen.de
Schäfer
Cora
C
Westenfeld
Ralf
R
Brandenburg
Vincent
V
Hidajat
Sylvia
S
Weber
Christian
C
Ketteler
Markus
M
Jahnen-Dechent
Willi
W
D000818:Animals; D001483:Base Sequence; D001794:Blood Pressure; D001798:Blood Proteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D002114:Calcinosis / Q000235:genetics*; D017931:DNA Primers; D003971:Diastole / Q000502:physiology*; D004195:Disease Models, Animal; D006321:Heart / Q000502:physiology*; D006331:Heart Diseases / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009206:Myocardium / Q000473:pathology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D060749:alpha-2-HS-Glycoprotein
C556357:Ahsg protein, mouse; D001798:Blood Proteins; D017931:DNA Primers; D060749:alpha-2-HS-Glycoprotein